Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Euro Biopharma 2017

Session/Tracks

Conference Series LLC  invites all the participants from all over the world to attend European Biopharma Congress during November 16-17, 2017 in Vienna, Austria which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

The  EuroBiopharma 2017 offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions on the topics  Cell Therapy, Biopharmaceutics, Drug delivery, Biotechnology, Gene Therapy, Therapeutic Biological Products, BABE, Biosimilars, Clinical Trails, Drug Discovery, current issues in Bioequivalence, Pharmaceutical Innovation in the 21st Century, new scientific approaches to international regulatory standards. Biopharmaceutical Companies & Market Analysis, The conference invites delegates from Biopharma laboratories, Pharmacists, Academicians, Clinicians, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects.

Track 1Biopharmaceutics: Drug Discovery and Development

The field of new drug development has moved its focus from small-molecule compounds to large-molecule proteins and other biopharmaceuticals. These biopharmaceuticals have caused an archetype shift in disease cure and has led to an enhancement in the quality of life of patients with various diseases such as autoimmune diseases, refractory cancers  biopharmaceuticals represent 7.5% of all drugs in the market and account for ~10% of the total expenses for marketed drugs. The usage of biopharmaceuticals are increasing at the rate >20% per year. They are already being used74% more than chemically derived pharmaceuticals, in life-saving or end-stage applications . Moreover, biopharmaceuticals covers > 30% of all pipeline research programs going-on at present which embraces all recombinant proteins, monoclonal antibodies, cytokines, peptides, vaccines, blood/plasma-derived products, non-recombinant culture-derived proteins, nucleic acid-based products (DNA, RNA or antisense oligonucleotides used for curative or in vivo diagnostic purposes), cells and tissues cultures. This view is possibly best understood by the public and mostly used by the people in the biopharmaceutical.

Related Biopharmaceutics Events | Biopharmaceutics Workshops

2nd International Conference on Molecular Biology , London, UK , June 22-24, 20173rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 20175th International Conference on Integrative Biology, London, UK ,June 19-21, 20172nd World Congress on Human Genetics, Chicago, USA, July 24-26, 20179th International Conference on Genomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017.

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS),

 Track 2:Therapeutic Biological Products

Products that are obtained from specific organs or tissues said to correspond with the unhealthy organs or tissues of the recipient. Proponents claim that the recipient's body automatically transports the injected cells to the target organs, where they supposedly strengthen them and regenerate their structure. The organs and glands used in cell treatment include brain, pituitary, thyroid, adrenals, thymus, liver, kidney, pancreas, spleen, heart, ovary, testis, and parotid. Several different types of cell or cell extract can be given simultaneously - some practitioners routinely give up to 20 or more at once.

Related Biopharmaceutics Conferences | Biopharmaceutics Meetings

3rd International Conference on Synthetic Biology, Munich, Germany, July 20-21, 2017;  5th International Conference and Exhibition on Cell and Gene Therapy, Madrid, Spain,Mar 2-3, 2017; International Conference on Cell Signalling and Cancer Therapy, Paris, France, Aug 20-22, 2017;  7th Annual Conference on Stem Celland Regenerative Medicine, Paris, France, Aug 04-05, 2016; 3rd International Conference & Exhibition on Tissue Preservation and Bio banking, Baltimore, USA,June 29-30, 2017.

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS),

Track 3: Cellular and Gene Therapy

Cell therapy as performed by alternative medicine practitioners is very different from the controlled research done by conventional stem cell medical researchers. Alternative practitioners refer to their form of cell therapy by several other different names including Immunotherapy, Allogenic Cell Therapy and fresh Neural Stem cell therapy. Proponents of cell therapy claim that it has been used successfully to rebuild damaged cartilage in joints, repair spinal cord injuries,strengthen a weakened immune system, treat autoimmune diseases such as AIDS, and help patients with neurological disorders such as Alzheimer’s disease, Parkinson's disease and epilepsy.

Gene therapy and cell therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in the DNA or cellular population, respectively. The development of suitable gene therapy treatments for many genetic diseases and some acquired diseases has encountered many challenges and uncovered new insights into gene interactions and regulation. Further development often involves uncovering basic scientific knowledge of the affected tissues, cells, and genes, as well as redesigning vectors, formulations, and regulatory cassettes for the genes.

Related Biopharmaceutics Conferences | Biopharmaceutics Meetings

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell ResearchOrlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21,2017; 2nd International Conference on Genetic Counselling and Genomic Medicine , Beijing, China, July 10-12, 2017; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017.

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS),

Track 4: Biologics and Biosimilars

The development of biologics calls for overcoming lot many challenges. With initial steps of concepts of biologics, their considerations, essentials for early clinical developments it is very much needed that proper scientific and strategic approaches are taken for the successful development of follow-on-biologics. Moreover, the need for overcoming the challenges continues in the late clinical steps, drug safety factors and labelling requirements. Also it is much required now to develop a drug product in accordance to quality by design (QbD). This Euro Biopharma 2017 conference will look at the multiple facets of current challenges in biosimilar development. This conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, potential and efficacious biologic products to the market.

Related Biopharmaceutics Conferences | Biopharmaceutics Meetings

12th Biosimilars Summit, January 24-25, 2017 ; International Conference on Drug Formulation, Bioavailability and Pharmacological Sciences, Jan 26-27, 2017, Innsbruck; American Society for Clinical Pharmacology and Therapeutics (ASCPT), March 15-18, 2017, Washington, DC;  International Symposium on Drug Delivery and Pharmaceutical Sciences, 09 - 10 March 2017, Kyoto Japan; 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia; 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE;7th European Biosimilars Congress, May 15-17, 2017, Munich, Germany; World Biosimilars congress, May 23-24, 2017, San Diego, USA;  International Conference on Pharmaceutical Preformulation and Biopharmaceutics, Jul 04-05, 2017, Singapore; 

Related Associations or Societies:Generic Pharmaceutical Association | US Food and Drug AdministrationFDA) | European Generic medicines Association | Therapeutics Goods Administration (TGA) | European Economic Area | Canadian Generic Pharmaceutical Association (CGPA) | Bioequivalence and Bioavailability forum  |  FDA Office of Surveillance and Epidemiology  | American Association for Clinical Chemistry (AACC) | American Association of Pharmaceutical Scientists (AAPS) | Clinical Trials Information from National Institutes for Health (NIH) | National Institute of Standards and Technology (NIST)

Track 5: Bioavailability & Bioequivalence studies of Biopharmaceuticals

The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed

Related Biopharmaceutics Conferences | Biopharmaceutics Meetings

International Conference on Drug FormulationBioavailability and Pharmacological Sciences, Jan 26-27, 2017, Innsbruck; American Society for Clinical Pharmacology and Therapeutics (ASCPT), March 15-18, 2017, Washington, DC;  International Symposium on Drug Delivery and Pharmaceutical Sciences, 09 - 10 March 2017, Kyoto Japan; 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia; 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE;7th European Biosimilars Congress, May 15-17, 2017, Munich, Germany; World Biosimilars congress, May 23-24, 2017, San Diego, USA;  International Conference on Pharmaceutical Preformulation and Biopharmaceutics, Jul 04-05, 2017, Singapore; 

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS),

Track 6: Clinical Trials on Biopharmaceuticals Products

Clinical Trials is a multidisciplinary program with broad participation with members from around the globe focused on learning about clinical research and its advances. This is your best opportunity to reach the largest assemblage of participants from Clinical Trials community that is from academia, clinical research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries. Clinical Trials  will discuss various disciplines involved in the pre-clinical research, conduct of clinical trials; it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of clinical trials. It promotes better understanding by the general public about the importance of clinical trials in prevention, diagnosis and treatment of disease.

Relevant Biopharmaceutics Events | Biopharmaceutics Workshops

2nd Biotechnology World Convention, London, UK, May 25-27, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017;  8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017.

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS),

Track 7: Biotechnological Products

Pharmaceutical Biotechnology is an increasingly important area of science and technology, and contributes to design and delivery of new therapeutic drugs, the development of diagnostic agents for medical tests, and the beginnings of gene therapy for correcting the medical symptoms of hereditary diseases. Pharmaceutical Biotechnology is pioneering in the UK, providing a detailed insight into the technologies that allow the development and production of biopharmaceuticals that could lead to cures for most major diseases.

Related  Biopharmaceutics Events | Biopharmaceutics Workshops

2nd Biotechnology World Convention, London, UK, May 25-27, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017;  8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017.

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS),

Track 8: Drug Delivery System

Drug Delivery system attains greater global significance as Drug Delivery System plays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. This includes topics like lipid Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. The major part is to deliver an innovative speech on the latest Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others Drug 

Relevant Biopharmaceutics Events | Biopharmaceutics Workshops

10th Conference on Pharmaceutics and Novel Drug Delivery Systems March 13-15, 2017 London UK; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA ; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th European Pharma Congress July 10-12  2017 Madrid, Spain. 

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS),

Track 9:Drug Disposition & Pharmacokinetics

Once a particular medicine is chosen, the principles of clinical pharmacokinetics are required to ensure the appropriate formulation of drug is chosen for an appropriate route of administration. On the basis of the patient’s drug handling parameters, which require an understanding of absorption, distribution, metabolism and excretion, the dosage regimen for the medicine in a particular patient can be developed. The pharmacist will then need to ensure that the appropriate regimen is prescribed to achieve optimal efficacy and minimal toxicity. Pharmacists then ensure that the appropriate monitoring is undertaken and that the patient receives the appropriate information to ensure compliance. Clinical pharmacokinetics  is thus a fundamental knowledge base that pharmacists require  to ensure effective practice of pharmaceutical care.

Relevant Biopharmaceutics Conferences | Biopharmaceutics Meetings

10th Conference on Pharmaceutics and Novel Drug Delivery Systems March 13-15, 2017 London UK; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA ; 7th Global Experts Meeting on Neuropharmacology July 31-Aug 02, 2017 Milan, Italy; 9th European Pharma Congress July 10-12  2017 Madrid, Spain. 

Related Associations or Societies:Association of the British Pharmaceutical Industry (ABPI), International Association for Pharmaceutical Technology(APV), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS), Chinese American BioPharmaceutical Society

Track 10: Biopharmaceutical Companies & Market analysis

Pharmaceutical analytic market research deals with the collection, analysis, and interpretation of details and information relating to the market environment of a given pharmaceutical product – in general of a medical drug. The primary objective of pharmaceutical market research is to gain as realistic and objective as possible an impression of the marketing opportunities of a given pharmaceutical product, thus enabling the identification of the chances and risks associated with its development potential as early on as possible.

 Relevant Biopharmaceutics Conferences | Biopharmaceutics Meetings

Conference on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia; Spain. 7th Conference on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 11th World Drug Delivery Summit October 16-18, 2017 New York, USA,

 Related Associations or Societies:National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), The International Society for Biopharmaceutical Statistics (ISBS), Chinese American BioPharmaceutical Society

Track 11: Pharmaceutical Regulatory Affairs And IPR 

Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the CGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is actually good common sense quality management quality assurance GMP production and quality control.

Related Biopharmaceutics Events | Biopharmaceutics Workshops

8th Global Pharmacovigilance  & Drug Safety Summit, April 17-18, 2017 Bali, Indonesia; 8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 9th International Conference and Exhibition on Pharmacovigilance, July 17-19, 2017 Munich, Germany; International Conference on Pharmaceutical and Biomedical Engineering June 12-13, 2017 Taipei, Taiwan.

Related Associations or Societies:Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE)European Association of Employed Community Pharmacists in Europe (EPhEU)Pharmaceutical Group of the European Union (PGEU).

Track 12: Biopharmaceutical Pharmacovigilance

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Euro Biopharma 2017  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. With members from around the world focused on learning about Pharmacovigilance and its advances;

Relevant Bio pharmaceutics Conferences | Bio pharmaceutics

8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit, June 26-28, 2017 San Deigo, USA; 110th Conference on Pharmaceutics and Novel Drug Delivery Systems March 13-15, 2017 London UK.

 Related Associations or Societies:Accreditation Council for Pharmacy Education (ACPE), Association of British Healthcare Industries (ABHI), Association of the British Pharmaceutical Industry (ABPI), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT)

 

About Conference

Euro Biopharma 2017 focuses upon “Latest Research Trends and Market Scopes of Biopharmaceuticals”.  This biopharma  meeting focuses on the trends which the biopharmaceutical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market.

Why to attend???

Join your peers around the world focused on learning about Biopharmaceutics, Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biopharma community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference. 

Target Audience: 

  • Biopharma, Biotech, Pharma Industry CEO, Directors, R&D Researchers
  • Business Entrepreneurs, Training Institutes, Software developing companies,
  • Medical Devices Manufacturing Companies, CRO
  • Data Management, Clinical Trial Conducting Organizations and Companies
  • Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences
  • Universities, Medical Colleges, Researchers from Pharmaceutical background

Market Analysis

The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the pharma market. It’s by far the fastest-growing part of the industry: biopharma’s current annual growth rate of more than 8% is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable future.

The world of Big Pharma is not only growing, it's standing on its head. Worldwide spending for prescription branded drugs and generic medicines will jump 30% from 2013-2018 at compound annual growth rate of over 5% leading to a jaw-dropping $1.3 trillion in annual global drug sales.The market is also radically shifting position, with traditional strongholds, such as Japan and Europe, flipping over, and emerging markets, such as China, becoming the head. The result is that healthcare investors need a new strategy; they need a way to keep an eye on emerging markets so they aren't left in the lurch because they don't understand the true engines for growth in their holdings. Germany is the leading pharmaceutical market in Europe, but its growth has also slowed to a crawl. The German drug sector is expected to expand at a modest 1.7% rate from 2015 to 2020. Life sciences is considered one of the most promising sectors of the Austrian economy. Austrian biotech firms are predominantly companies with a pure research focus, over half of which are involved in the health sector. A high percentage of companies work in research and the research rate of the Austrian biotechnology industry stands at 21%. Small and medium enterprise accounts for the majority of Austrian pharmaceutical firms, with large-scale companies at just 10%. 

Global Pharmaceutical Market Growth Rate Percentage:

Projection of Pharma sales in Europe:

Past Conference Report

Biopharma 2016

We gratefully thank all our wonderful Keynote Speakers, Speakers, Conference Attendees, Students, Media Partners, Associations, Sponsors and Exhibitors for making Biopharma 2016 Conference successful!

The 2nd International Conference on Biopharmaceutics and Biologic Drugs, hosted by the Conferenceseries LLC was held during September 14-16 2016 at San Antonio, USA based on the theme Biopharmaceutics the Life within Drugs”. Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Biopharmaceutics, Biotech, Medical and pharmacy, who made this event a grand success.

Conferenceseries LLC expresses its gratitude to the conference Moderator, namely Maysaa Ch Al Mohammedawi for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Chairs of the sessions for 2 days, namely Teimuraz Lezhava, R K Purohit, and Sihem Bihorel.

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

  • Arie Regev, Indiana University and Eli Lilly, USA
  • Teimuraz Lezhava, Tbilisi State University, Georgia

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Drug Discovery & Development
  • Drug Elimination & Clearance
  • Biological Medicine
  • Herbal Drug Interactions
  • Forms of Drug Delivery System
  • Protein Interactions as Targeted Therapeutics
  • Clinical Trial Supply Management
  • Therapeutic Drug Monitoring and Drug Quantification
  • Pharmacovigilance and Drug Safety
  • Novel Approaches in Biopharmaceutics
  • Pharmaceutical Innovations in 21st Century
  • Current Issues in Bioavailability & Bioequivalence
  • Nanoparticles-An Innovative Drug Delivery System

Conference Series LLC offers its heartfelt appreciation to organizations such as Pharma Voice, Event listing sites and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 16-17, 2017

For Sponsors & Exhibitors

Sponsorship Opportunities

Speaker Opportunity

Supported By

Clinical Pharmacology & Biopharmaceutics: Open Access Journal of Bioequivalence & Bioavailability Journal of Drug Metabolism & Toxicology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by